These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28427505)

  • 1. Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies.
    Leitch HA; Fibach E; Rachmilewitz E
    Crit Rev Oncol Hematol; 2017 May; 113():156-170. PubMed ID: 28427505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of iron overload in hematopoietic stem cell transplantation.
    Wang C; Zhao M; Liu Q; Yang Y; Li Y; Nie Y; Gao S; Li W
    Transpl Immunol; 2023 Jun; 78():101820. PubMed ID: 36921731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
    Kim YR; Kim JS; Cheong JW; Song JW; Min YH
    Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.
    Leitch HA
    Drugs; 2011 Jan; 71(2):155-77. PubMed ID: 21275444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study.
    Messa E; Biale L; Castiglione A; Lunghi M; Bonferroni M; Salvi F; Allione B; Ferrero D; Calabrese C; De Gobbi M; Nicoli P; Gioia D; Levis A; Saglio G; Cilloni D
    Leuk Lymphoma; 2017 Nov; 58(11):2752-2754. PubMed ID: 28482720
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of iron metabolism in myelodysplastic syndromes].
    Finelli C; Clissa C; Stanzani M
    Recenti Prog Med; 2014 Mar; 105(3):123-6. PubMed ID: 24675455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies surrounding iron chelation therapy for MDS.
    Leitch HA
    Blood Rev; 2011 Jan; 25(1):17-31. PubMed ID: 21030120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron and oxidative stress in cardiomyopathy in thalassemia.
    Berdoukas V; Coates TD; Cabantchik ZI
    Free Radic Biol Med; 2015 Nov; 88(Pt A):3-9. PubMed ID: 26216855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observational Monitoring of Patients with Aplastic Anemia and Low/Intermediate-1 Risk of Myelodysplastic Syndromes Complicated with Iron Overload.
    Du Y; Long Z; Chen M; Han B; Hou B; Feng F
    Acta Haematol; 2017; 138(2):119-128. PubMed ID: 28866669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron overload and toxicity: the hidden risk of multiple blood transfusions.
    Shander A; Cappellini MD; Goodnough LT
    Vox Sang; 2009 Oct; 97(3):185-97. PubMed ID: 19663936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into transfusion-related iron toxicity: Implications for the oncologist.
    Porter JB; de Witte T; Cappellini MD; Gattermann N
    Crit Rev Oncol Hematol; 2016 Mar; 99():261-71. PubMed ID: 26806144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation.
    Atilla E; Toprak SK; Demirer T
    Turk J Haematol; 2017 Mar; 34(1):1-9. PubMed ID: 27956374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases.
    Cattoni A; Capitoli G; Casagranda S; Corti P; Adavastro M; Molinaro A; Di Gennaro F; Bonanomi S; Biondi A; Galimberti S; Balduzzi A
    Transplant Cell Ther; 2023 Apr; 29(4):271.e1-271.e12. PubMed ID: 36708803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment and management of post-transplant iron overload: Guidelines of the Francophone Society of Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Jaspers A; Bouhya S; Belaiche S; Chevallier P; Hermet E; Hospital-Gustems C; Michallet M; Rialland F; Samsonova O; Sirvent A; Yakoub-Agha I; Rohrlich PS; Beguin Y
    Bull Cancer; 2016 Nov; 103(11S):S255-S266. PubMed ID: 27842863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron overload and chelation therapy in myelodysplastic syndromes.
    Temraz S; Santini V; Musallam K; Taher A
    Crit Rev Oncol Hematol; 2014 Jul; 91(1):64-73. PubMed ID: 24529413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation.
    Akı ŞZ; Suyanı E; Cengiz M; Özenirler S; Elbeğ Ş; Paşaoğlu H; Sucak GT
    Biol Blood Marrow Transplant; 2015 May; 21(5):948-53. PubMed ID: 25681034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?
    Leitch HA; Vickars LM
    Hematology Am Soc Hematol Educ Program; 2009; ():664-72. PubMed ID: 20008252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapy.
    Shander A; Sazama K
    Transfusion; 2010 May; 50(5):1144-55. PubMed ID: 20088842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.
    Meyer SC; O'Meara A; Buser AS; Tichelli A; Passweg JR; Stern M
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):440-4. PubMed ID: 23089566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.